Los Angeles, CA, United States of America

Qinqin Cheng

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Therapy by Qinqin Cheng

Introduction

Qinqin Cheng is an accomplished inventor based in Los Angeles, CA. He has made significant contributions to the field of cancer therapy through his innovative research and patented technologies. His work focuses on developing novel therapies that enhance the efficacy of cancer treatments.

Latest Patents

Qinqin Cheng holds a patent for "Synthetic extracellular vesicles for novel therapies." This invention addresses the growing issue of tumor cells developing resistance to existing chemotherapeutic and targeted therapeutic agents. The patent describes extracellular nanoparticle vesicles that redirect immune effector cells towards cancer cells, promoting their destruction. Unlike conventional immunotherapeutic antibodies, which have defined orientation and geometry, antibodies displayed on spherical exosomes can enhance the formation of immunological synapses and improve the activation of immune cells.

Career Highlights

Cheng is affiliated with the University of Southern California, where he conducts his research and develops his innovative therapies. His work has garnered attention for its potential to revolutionize cancer treatment and improve patient outcomes.

Collaborations

Cheng collaborates with notable colleagues, including Yong Zhang and Xiaojing Shi, who contribute to his research efforts and the advancement of cancer therapies.

Conclusion

Qinqin Cheng's innovative work in developing synthetic extracellular vesicles represents a significant advancement in cancer therapy. His contributions have the potential to enhance the effectiveness of treatments and provide new hope for patients battling cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…